Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment

Podobne zapisy

• Predictive value of cytokines and immune activation biomarkers in AIDS-related non-Hodgkin lymphoma treated with rituximab plus infusional EPOCH (AMC-034 trial)
  od: Epeldegui, Marta, i wsp.
  Wydane: (2015)
• Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma
  od: Epeldegui, Marta, i wsp.
  Wydane: (2015)
• Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL
  od: Epeldegui, Marta, i wsp.
  Wydane: (2019)
• Author Correction: Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL
  od: Epeldegui, Marta, i wsp.
  Wydane: (2020)
• TLR2 activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS related non-Hodgkin lymphoma (NHL) diagnosis
  od: Guo, Yu, i wsp.
  Wydane: (2013)